Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design and Implementation of Improved SARS-CoV-2 Diagnostic Assays To Mitigate the Impact of Genomic Mutations on Target Failure: the Xpert Xpress SARS-CoV-2 Experience.
Burns BL, Moody D, Tu ZJ, Nakitandwe J, Brock JE, Bosler D, Mitchell SL, Loeffelholz MJ, Rhoads DD. Burns BL, et al. Among authors: brock je. Microbiol Spectr. 2022 Dec 21;10(6):e0135522. doi: 10.1128/spectrum.01355-22. Epub 2022 Oct 18. Microbiol Spectr. 2022. PMID: 36255326 Free PMC article.
Endemic SARS-CoV-2 Polymorphisms Can Cause a Higher Diagnostic Target Failure Rate than Estimated by Aggregate Global Sequencing Data.
Rhoads DD, Plunkett D, Nakitandwe J, Dempsey A, Tu ZJ, Procop GW, Bosler D, Rubin BP, Loeffelholz MJ, Brock JE. Rhoads DD, et al. Among authors: brock je. J Clin Microbiol. 2021 Jul 19;59(8):e0091321. doi: 10.1128/JCM.00913-21. Epub 2021 Jul 19. J Clin Microbiol. 2021. PMID: 33972454 Free PMC article. No abstract available.
A Model for Design and Implementation of a Laboratory Information-Management System Specific for Molecular Pathology Laboratory Operations.
Tomlinson E, Goodman J, Loftus M, Bitto S, Carpenter E, Oddo R, Judis L, Ali S, Robinson WE, Carver M, Ganea M, McDonnell K, O'Neill D, Starbuck J, Johnson E, Meister E, Pohl J, Spildener J, Shurtleff S, Sovie S, Melendez C, Krebs P, Riley JD, Wensel C, Astbury C, Azzato EM, Bosler DS, Brock JE, Cook JR, Cheng YW, Tu ZJ, Cruise M, Henricks WH, Farkas DH. Tomlinson E, et al. Among authors: brock je. J Mol Diagn. 2022 May;24(5):503-514. doi: 10.1016/j.jmoldx.2022.01.002. Epub 2022 Jan 31. J Mol Diagn. 2022. PMID: 35101595 Free article.
Concordance of PD-L1 Expression in Metastatic Triple-negative Breast Cancer Between the 22C3 and E1L3N Antibodies Using Combined Positive Scoring.
Erick TK, Lester SC, Garrido-Castro AC, Hughes M, Cunningham O, Lin NU, Mittendorf EA, Tolaney SM, Brock JE. Erick TK, et al. Among authors: brock je. Appl Immunohistochem Mol Morphol. 2024 Sep 20. doi: 10.1097/PAI.0000000000001223. Online ahead of print. Appl Immunohistochem Mol Morphol. 2024. PMID: 39351784
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.
Lynce F, Stevens LE, Li Z, Brock JE, Gulvady A, Huang Y, Nakhlis F, Patel A, Force JM, Haddad TC, Ueno N, Stearns V, Wolff AC, Clark AS, Bellon JR, Richardson ET, Balko JM, Krop IE, Winer EP, Lange P, Hwang ES, King TA, Tolaney SM, Thompson A, Gupta GP, Mittendorf EA, Regan MM, Overmoyer B, Polyak K. Lynce F, et al. Among authors: brock je. Breast Cancer Res. 2024 Jan 31;26(1):20. doi: 10.1186/s13058-024-01774-0. Breast Cancer Res. 2024. PMID: 38297352 Free PMC article. Clinical Trial.
Identifying Patterns and Barriers in OncotypeDX Recurrence Score Testing in Older Patients With Early-Stage, Estrogen Receptor-Positive Breast Cancer: Implications for Guidance and Reimbursement.
Trapani D, Jin Q, Block CC, Freedman RA, Lin NU, Tarantino P, Mittendorf EA, King TA, Lester SC, Brock JE, Tayob N, Bunnell CA, Tolaney SM, Burstein HJ. Trapani D, et al. Among authors: brock je. JCO Oncol Pract. 2023 Aug;19(8):560-570. doi: 10.1200/OP.22.00731. Epub 2023 May 16. JCO Oncol Pract. 2023. PMID: 37192427 Free article.
110 results